Anglo American has initiated a formal process to sell its coal assets and explore options for its nickel operations to thwart BHP's takeover threat and stay independent, according to CEO Duncan Wanblad.

Fusion Pharmaceuticals shareholders have overwhelmingly approved its ~$2B acquisition by AstraZeneca, expected to close by the end of Q2.

"BHP (NYSE:BHP) seeks an extension for talks with Anglo American (OTCQX:AAUKF) on its takeover proposal, citing proposed socioeconomic measures and the need for further engagement, with the deadline for merger talks looming."

Braavo Capital has closed a $5mn Series B funding round and a new $30mn debt fund to expand its Growth Ventures initiative focused on web monetization.